On August 26, 2020, Li Quanqing, Member of the Party Leadership Group and Deputy Director of Lishui Municipal Market Supervision Bureau, Wu Chaqing, Director of the Drug Quality Testing Center of Lishui Municipal Institute of Quality Inspection and Testing, and their entourage visited Zhejiang Benefit Pharmaceutical to carry out the "Three Services" activity aimed at serving enterprises. Wu Xiaohua, Deputy General Manager of Commercial Affairs, and senior executives of the pharmaceutical company accompanied the research.

Zhang Liyun, Administrative Director, gave a brief introduction to the company's overview, corporate culture, and the production process of the company's traditional Chinese medicine formula granules. Through a remote real-time video system, she detailed the various production links and inspection and testing of Chinese herbal pieces and traditional Chinese medicine formula granules. Subsequently, they visited the QC Inspection and Testing Center of the Quality Management Department, conducted on-site work guidance, and held in-depth exchanges and discussions on relevant issues.

At the forum, Deputy General Manager Wu Xiaohua first expressed his gratitude to Deputy Director Li Quanqing and his entourage from Lishui Municipal Market Supervision Bureau for their visit, and made a detailed report on the company's recent situation, the construction of professional and technical talent teams, and the strategic planning for the company's future development.

After listening to the report, the two parties conducted in-depth discussions and exchanges on how to improve the company's inspection and testing capabilities, how to strengthen the professional skills of the company's professional inspection and testing personnel, how to carry out effective communication and exchanges between the two parties, and the problems encountered in inspection and testing work. Director Wu Chaqing provided detailed suggestions and guidance on the professional training of inspectors and the key points of inspection details.

Deputy Director Li Quanqing highly affirmed the company's clear positioning for future development and Benefit's layout and persistence in the development of the modern traditional Chinese medicine industry over the past decade. Quality is the life of an enterprise, and the quality of pharmaceuticals is related to the lives of consumers and the survival of the enterprise. Deputy Director Li Quanqing stated that as a supervisory and management department, it has the obligation and responsibility to supervise enterprises while providing assistance, work together with enterprises to ensure product quality, and jointly promote the rapid development of Lishui's green ecological traditional Chinese medicine industry economy.